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To repair complex congenital heart defects, surgeons arerequired to use extreme techniques, such as cardiopul-monary bypass (CPB) with deep hypothermic circula-tory arrest (DHCA). Several investigators have shown
that DHCA has a significant adverse effect on the cerebral blood
flow (CBF) and metabolism in neonates and infants, as well as in
animal models.1-3 However, we have shown, in a neonatal piglet
model, that the use of pulsatile flow might minimize these adverse
events by increasing the regional and global CBF, cerebral meta-
bolic rate of oxygen, and cerebral oxygen delivery and by decreas-
ing cerebral vascular resistance.4 In a separate study we have also
shown that, compared with nonpulsatile roller pumps, pulsatile
roller pumps generate significantly more hemodynamic energy and
increase cerebral, renal, and myocardial blood flow after DHCA.5-7
The objectives of the present study were (1) to compare the
effects of pulsatile perfusion versus nonpulsatile perfusion with a
new pediatric roller pump equipped with a miniature roller head on
regional and global CBF and on regional cerebral oxygen satura-
tion (rSo2) and (2) to quantify and directly compare the resulting
pressure and flow waveforms in terms of hemodynamic energy by
using the energy equivalent pressure (EEP) formula. The EEP
formula is the best for quantifying different modes of perfusion
because it contains both pressure and flow waveforms and not just
pressure waveforms alone.8
Materials and Methods
Animals. Fourteen piglets (mean weight, 3 kg) underwent ei-
ther pulsatile perfusion (n  7) or nonpulsatile perfusion (n  7).
All animals received humane care as described in the “Guide for
the Care and Use of Laboratory Animals” of the National Research
Council.
Perfusion protocol. Each piglet was premedicated with intra-
muscular ketamine hydrochloride (20 mg/kg) and acepromazine
maleate (1 mg/kg; INN: acepromazine). An intravenous line was
established, after which a 3-mm endotracheal tube was inserted for
mechanical ventilation. Intravenous boluses of fentanyl citrate
(100 g/kg) and pancuronium bromide (0.3 mg/kg) were then
given. During CPB, anesthesia was maintained with continuous
isoflurane (1%-5%) by means of oxygenator gas inflow. A median
sternotomy was performed, after which the ascending aorta and
right atrium were cannulated with a 10F aortic cannula (DLP, Inc,
Grand Rapids, Mich) and a 21F single-stage venous cannula
(Polystan A/S, Varlose, Denmark), respectively. The extracorpo-
real circuit was primed with heparinized fresh blood and lactated
Ringer’s solution. The priming volume for the whole circuit was
approximately 600 mL. During CPB, the hematocrit level was
maintained at 24% to 26% in both groups. Equipment used in the
circuit included a Sto¨ckert SIII mast-mounted roller pump with a
miniature roller head (Sto¨ckert, Munich, Germany) for producing
pulsatile and nonpulsatile flow, a hollow-fiber membrane oxygen-
ator (Capiox SX10; Terumo Corp, Tokyo, Japan), and a pediatric
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arterial filter (Terumo Corp). During pulsatile CPB, the pump rate
was maintained at 150 beats/min. Pump flow was maintained at
150 mL  kg1  min1 in both groups. An ultrasonic flow probe
(T109; Transonic Systems, Inc, Ithaca, NY) was placed in the
circuit, beyond the membrane oxygenator, to measure blood flow.
In all experiments phenoxybenzamine (1 mg/kg), a potent vasodi-
lator and -adrenergic blocker, was administered 5 minutes before
initiation of CPB. During CPB, the mean arterial pressure (MAP)
was maintained at 45 mm Hg by adding isoflurane through the
oxygenator gas inflow conduit in both groups. During the 60-
minute aortic crossclamping period, the temperature was kept at
18°C in both groups. After the ascending aorta was crossclamped,
a 40-mL dose of crystalloid cardioplegic (modified Kirklin) solu-
tion was manually administered into the aorta. At the end of each
experiment, the piglet was killed with an intravenous bolus of
pentobarbital sodium and phenytoin sodium (Beuthanasia-D, 0.22
mg/kg).
Experimental design. Both experimental groups underwent
hypothermia for 25 minutes, DHCA for 60 minutes, cold reperfu-
sion for 10 minutes, and rewarming for 40 minutes. During cooling
and rewarming, alpha-stat management was used. Rectal temper-
ature was measured continuously in both groups.
Radioactive microspheres, 15 m in diameter (51Cr, 95Nb,
141Ce, 46Sc), were used to measure regional and global CBF. In
both experimental perfusion groups, microspheres were injected
(1) before CPB, (2) during normothermic CPB at 36°C, (3) during
deep hypothermia at 18°C, and (4) 30 minutes after CPB. Micro-
spheres were injected into the site of the arterial line 40 cm
proximal to the aortic cannula during CPB and into the left atrial
catheter before and after CPB. A reference blood sample was
withdrawn from the femoral artery before each injection at a pump
flow rate of 2 mL/min. At the end of each experiment, the brain
was removed and dissected. The left and right cerebral hemi-
spheres, cerebellum, basal ganglia, and brain stem were then
placed in preweighted tubes for gamma counting. The radiolabeled
microsphere technique is detailed elsewhere.4,6
rSO2 measurements. For continuous monitoring of the rSO2
of the mixed arterial and venous blood in the brain cortex, a
pediatric near-infrared (NIR) spectroscope (INVOS Model 5100;
Somanetics Corp, Troy, Mich) was used. This device passed
low-intensity NIR light into the subject’s forehead through the
skull and the cerebral cortex. The degree of spectral absorption by
the cerebral circulation was indicated by the intensity of the
reflected light 3 and 4 cm from the light source. Light absorption
data were collected 15 times per second and were stored on a
diskette for computer analysis.
Quantification of pulsatile and nonpulsatile pressure-flow
waveforms. The following formula is used to define EEP (8):
EEP  (pdt)/(dt),
where f is the pump flow rate (in milliliters per second), p is the
arterial pressure, and the time integrals are over one pulse cycle.
The EEP is the ratio of the areas beneath the hemodynamic power
curve (pdt) and pump flow rate curve (dt) at the end of the flow
and pressure cycles. The EEP is expressed in millimeters of
mercury.
Waveforms of the femoral MAP, precannulation extracorporeal
circuit pressure, and pump flow were acquired at 3 experimental
stages: (1) during normothermic CPB (15 minutes on pump at
36°C); (2) during deep hypothermic CPB (immediately before
DHCA at 18°C); and (3) after rewarming (after 60 minutes of
DHCA, 10 minutes of cold reperfusion, and 40 minutes of rewarm-
ing). Data were recorded by using data acquisition software for 15
seconds at a rate of 100 Hz.
Statistical analysis. Two-sided analysis of variance with re-
peated measures was used for statistical analysis of data from the
pulsatile and nonpulsatile perfusion groups. All regional and
global CBF results were expressed as means  SEM.
Results
There were no intergroup differences in hematocrit level, temper-
ature, arterial oxygen tension, and arterial carbon dioxide tension
at any of the 4 experimental stages.
Global CBF. In both groups global CBF diminished during
normothermic CPB compared with before CPB (115.4  9.7
mL/100 g per minute vs 68  4.1 mL/100 g per minute, P  0.05
in the pulsatile perfusion group; 131.3  12.1 mL/100 g per
minute vs 69.8  4 mL/100 g per minute, P  .05 in the
nonpulsatile perfusion group; Figure 1). During deep hypothermic
CPB or 30 minutes after CPB, there were no intergroup differences
in global CBF.
Figure 1. Global CBF (mean SEM). †P < .05 versus pre-CPB flow
within pulsatile perfusion group; ‡P < .05 versus pre-CPB flow
within nonpulsatile perfusion group. P, Pulsatile; NP, nonpulsa-
tile.
Figure 2. Regional cerebral oxygen saturation (mean  SEM).
*P < .05 pulsatile versus nonpulsatile perfusion groups; †P < .05
versus pre-CPB flow within pulsatile perfusion group; ‡P < .05
versus pre-CPB flow within nonpulsatile perfusion group. P, Pul-
satile; NP, nonpulsatile.
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Left and right cerebral hemispheric blood flow. There were
no intergroup differences in left cerebral hemispheric blood flow at
any of the 4 experimental stages (Table 1). However, blood flow in
the left cerebral hemisphere diminished by 30 minutes after CPB
in both the pulsatile and nonpulsatile perfusion groups (27.5 1.4
mL/100 g per minute vs 31.3  3.2 mL/100 g per minute, P 
.43). The right cerebral hemispheric blood flow resembled the left
cerebral hemispheric blood flow (Table 1).
rSO2 saturation. There were no intergroup differences in rSO2
before CPB (49.3%  1.7% vs 46.4%  3.7%, P  .83), during
normothermic CPB (54.9%  3.2% vs 54.7%  3.1%, P  .54),
or during deep hypothermic CPB (86.3% 2.5% vs 88% 1.9%,
P  .42; Figure 2). However, rSo2 was significantly higher in the
pulsatile perfusion group than in the nonpulsatile perfusion group
after CPB (45.3%  1.6% vs 38.8%  2.6%, P  .05).
EEP (from MAP to EEP). There were no intergroup differ-
ences in EEP in the femoral artery during normothermic CPB
(0.3 1.6 mm Hg vs0.2 1.8 mm Hg, P .94), during deep
hypothermic CPB (0.2  1.4 mm Hg vs 0.4  0.7 mm Hg, P
 .83), or after rewarming (1.8 1.7 mm Hg vs0.9 2.2 mm
Hg, P  .54).
EEP (from extracorporeal circuit pressure to EEP). There
were no intergroup differences in EEP in the precannulation ex-
tracorporeal circuit during normothermic CPB (1.2  3 mm Hg vs
1.3 1.8 mm Hg, P .64), during deep hypothermic CPB (2.6
2.2 mm Hg vs 1  0.2 mm Hg, P  .44), or after rewarming
(0.5  1.4 mm Hg vs 0.7  1.3 mm Hg, P  .71).
MAP and pulse pressure. There were no differences in MAP
between the groups before CPB (44.3 2 mm Hg vs 48 3.7 mm
Hg, P  .38), during normothermic CPB (44.3  3.2 mm Hg vs
42.8  1.5 mm Hg, P  .72), before DHCA (44.4  2.4 mm Hg
vs 44.6  1.2 mm Hg, P  .95), after rewarming (46.4  2.8 mm
Hg vs 46.4  4.5 mm Hg, P  .98), or after CPB (50.8  6 mm
Hg vs 46.8  4.6 mm Hg, P  .35).
There were no intergroup differences in pulse pressure before
CPB (22.3  2.2 mm Hg vs 22  3.5 mm Hg, P  .90), during
CPB (8.6  2.8 mm Hg vs 5  0.4 mm Hg, P  .14), before
DHCA (5.3  0.5 mm Hg vs 4.6  0.7 mm Hg, P  .76), after
rewarming (7.6  1.3 mm Hg vs 5.3  1.3 mm Hg, P  .34), or
after CPB (22.7  1.8 mm Hg vs 22.4  1.1 mm Hg, P  .90).
Discussion
In our previous experiments we documented that pulsatile pumps
(hydraulically driven or roller) generate significantly more hemo-
dynamic energy than do conventional nonpulsatile roller pumps.5,7
This extra energy produced by pulsatile pumps might maintain
better microcirculation.5-7 In the present study we found no dif-
ferences in hemodynamic energy levels produced by pulsatile
versus nonpulsatile pumps. In fact, the particular pediatric pulsatile
roller pump used in this study, which had a miniature roller head,
failed to produce more energy. This might be why there were no
differences in regional and global CBF and cerebral oxygenation
between groups. The pulse pressures between groups were also
similar during CPB. When the temperature was reduced from 36°C
to 18°C, rSO2 significantly increased in both groups as a result of
the increase in metabolic oxygen suppression. There were no
intergroup differences in rSO2 levels during CPB. Deep hypother-
mic CPB with DHCA severely impaired cerebral hemodynamics
in both groups after CPB.
For many years, our laboratory has been interested in the
effects of pulsatile perfusion on cerebral, renal, and myocardial
recovery after hypothermic CPB with or without the use of DHCA
in a pediatric model.3-7 We have also tested all Food and Drug
Administration–approved pediatric pulsatile roller pumps cur-
rently available in the United States, as well as other experimental
pumps (not Food and Drug Administration approved), in the
identical experimental setting used in this current study.5 In all our
previous experiments, we have clearly documented that cerebral,
renal, and myocardial recovery after DHCA is significantly better
when the pulsatile flow is used.4,6,7 In addition, in those earlier
experiments we have also shown that the hemodynamic energy
produced by all other pulsatile pumps, except the one used in the
current study, generated higher hemodynamic energy compared
with the nonpulsatile roller pumps.5 The results of this study
clearly show that not all pulsatile pumps are truly pulsatile. We
believe that each study that investigates the effects of perfusion
modes on vital organ blood flow should also include the hemody-
namic energy generated by each of the pulsatile and nonpulsatile
devices. The readers of any article on perfusion modes should
know whether there is a difference in hemodynamic energy, along
with other physiologic parameters. Therefore we urge other inves-
tigators to use the EEP formula for a precise quantification of
pressure and pump flow waveforms between different modes of
perfusion or different forms of pulsatility for a direct and mean-
ingful comparison.5
Despite the negative results on this particular study, we truly
believe that pulsatile perfusion is superior to the nonpulsatile flow
on cerebral, renal, and myocardial recovery, when the adequate
TABLE 1. Regional cerebral blood flow*
Region
Pre-CPB On CPB Pre-DHCA Post-CPB
P NP P NP P NP P NP
Left cerebral hemisphere 100.2 8.7 118.7 11.5 56.2 3.3† 61.4 4.5† 54.6 5.6† 49.2 3.8‡ 27.5 1.4† 31.3 3.2‡
Right cerebral hemisphere 102.6 16.6 117.3 11.3 58.2 3† 59.7 4.6‡ 55.9 5.3† 47.6 3.4‡ 28.4 1.5† 31 3.3‡
Basal ganglia and thalamus 134 13.5 144.1 14.2 84.2 8.6† 77.4 6.7‡ 80.7 10.7† 69.7 6.2‡ 37.7 2.9† 37.7 4.1‡
Brain stem 167.7 14.7 166.5 14.6 116.9 9.9† 102.8 8.2‡ 111 11.8† 93.1 7.2‡ 41.1 4.7† 40.4 4‡
Cerebellum 165.6 12.9 187 17.2 101.1 5.6† 110.5 12.2‡ 91.8 8.7† 79.6 6.9‡ 57.1 5.1† 63 5.5‡
P, Pulsatile; NP, nonpulsatile; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.
*Mean  SEM (mL  100 g1  min1).
†P  .05 vs pre-CPB within pulsatile group.
‡P  .05 vs pre-CPB within nonpulsatile group.
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pulsatility is achieved.3-7 We also believe that our current results
correlated well with our earlier publications.
In summary, our present data indicate that a pediatric pulsatile
roller pump equipped with a miniature roller head is no better than
a nonpulsatile pump equipped with a miniature roller head at
generating adequate hemodynamic energy or maintaining cerebral
hemodynamics during CPB with DHCA. The data also suggest
that (1) NIR spectroscopy, both real time and noninvasive, is a
useful technique for monitoring rSO2, and (2) the EEP formula
should be used to evaluate directly and comparatively the benefits
of pulsatile perfusion.
We thank Kathleen McKay, BS, for technical assistance during
the experiments.
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